Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like Particles (VLP) Quadrivalent Influenza Vaccine in the Elderly Population
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Medicago
- 09 May 2016 Planned End Date changed from 1 Sep 2015 to 1 Jun 2016.
- 24 Sep 2015 Planned End Date changed from 1 Jun 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
- 24 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.